Versartis Reports Confirmatory Top-Line Two-Year Data from Ongoing Extension Study of Somavaratan in GHD Children Safe and well tolerated over two years Height velocity (HV) in second year comparable to published US rhGH daily dosing data; further confirms Phase 3...
AiCure’s Artificial Intelligence Platform Draws $12.25 Million Series A (New York, NY) – January 11, 2016 – AiCure, an artificial intelligence company connecting the world’s patients to better treatments and improved health, has closed a Series...
Recent Comments